Possible Safer Target for Anti-clotting Drugs Found

**Researchers at the University of Illinois at Chicago College of Medicine have identified a new molecular target in blood clot formation, which seems to reduce clotting without excessive bleeding, the common side-effect of anti-clotting agents.** The findings are reported in the September issue of Molecular and Cellular Biology. "It was very surprising to find an enzyme whose inhibition lessened platelet aggregation without abnormal bleeding, and we immediately realized that it could have very important implications for the treatment of cardiovascular disease," said Shafi Kuchay, a graduate student in pharmacology and first author of the paper. Whole article on "BIO":[ http://www.bio.com/newsfeatures/newsfeatures_research.jhtml;jsessionid=U0D0BXSIERLUJR3FQLMSFEWHUWBNQIV0?cid=34000008]

---